An Approach to Gynecomastia in Primary Care Clinics

Gynecomastia occurs more commonly in adult males than is often recognized and is, therefore, not evaluated. The workup should be based on the patient’s presentation and important clinical factors, including underlying medical disorders and medications. Patients without symptoms probably do not need additional evaluation unless an underlying clinical disorder is suspected. Ultrasonography of the breast is not routinely recommended. Gynecomastia will regress spontaneously in many patients but can be treated medically or surgically based on patient preference. It is not a premalignant condition and patients need this reassurance. Abstract Gynecomastia is a more common finding in primary care clinics than is recognized. Because this finding can be easily overlooked, appropriate investigation and management often are missed. The workup of gynecomastia is highly individualized, based on the patient’s presentation and related factors. It should be guided by thorough history taking and physical examination. Unless the patient has associated symptoms, or there is suspicion for an underlying clinical disorder causing the gynecomastia, the patient need not be investigated further. A breast ultrasound is not routinely recommended. Gynecomastia is a benign finding that will spontaneously regress in most patients; however, patients who are concerned with their physical appearance can be treated either medically or surgically. Patients who have had gynecomastia for more than 1 year tend to have fibrosis, which may be more difficult to treat. Management of gynecomastia is highly patient centered, following a detailed discussion about treatment goals and should be started early. Gynecomastia is not considered a premalignant condition; routine screening is not cost-effective, and imaging studies should be pursued only if physical examination findings suggest malignancy.

[1]  M. Tirona,et al.  An updated review of epidemiology, risk factors, and management of male breast cancer , 2021, Medical Oncology.

[2]  Y. Suh,et al.  Incidental Gynecomastia on Thoracic Computed Tomography in Clinical Practice: Characteristics, Radiologic Features, and Correlation With Possible Causes in South Korean Men , 2020, American journal of men's health.

[3]  J. Toppari,et al.  EAA clinical practice guidelines—gynecomastia evaluation and management , 2019, Andrology.

[4]  Su Hong Kim,et al.  Ultrasonographic and Mammographic Findings of Male Breast Disease , 2019, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[5]  함기선,et al.  Gynecomastia , 1974, Breast Diseases.

[6]  R. Rey,et al.  Clinical and Etiological Aspects of Gynecomastia in Adult Males: A Multicenter Study , 2018, BioMed research international.

[7]  Neda Jafarian,et al.  Male Breast: Clinical and Imaging Evaluations of Benign and Malignant Entities with Histologic Correlation. , 2016, The American journal of medicine.

[8]  J. Thompson,et al.  Gynecomastia and psychological functioning: A review of the literature. , 2015, Body image.

[9]  G. Rea,et al.  Breast ultrasound in the management of gynecomastia in Peutz–Jeghers syndrome in monozygotic twins: two case reports , 2014, Journal of Medical Case Reports.

[10]  W. Willett,et al.  Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. , 2014, Journal of the National Cancer Institute.

[11]  Harold E Carlson,et al.  Approach to the patient with gynecomastia. , 2011, The Journal of clinical endocrinology and metabolism.

[12]  A. Nowakowski,et al.  Gynecomastia - a difficult diagnostic problem. , 2011, Endokrynologia Polska.

[13]  D. Evans,et al.  Risk of breast cancer in male BRCA2 carriers , 2010, Journal of Medical Genetics.

[14]  B. Bonanni,et al.  Male breast cancer. , 2010, Future oncology.

[15]  M. Messina Soybean isoflavone exposure does not have feminizing effects on men: a critical examination of the clinical evidence. , 2010, Fertility and sterility.

[16]  A. Dobs,et al.  Drug-induced gynecomastia , 2008, Expert opinion on drug safety.

[17]  I. Cullen,et al.  Gynaecomastia: an endocrine manifestation of testicular cancer , 2008, Andrologia.

[18]  A. Schorer,et al.  Gynaecomastia and breast cancer in men , 2008, BMJ : British Medical Journal.

[19]  G. Braunstein,et al.  Clinical practice. Gynecomastia. , 2007, The New England journal of medicine.

[20]  R. Autorino,et al.  Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial. , 2005, The Lancet. Oncology.

[21]  M. Battaglia,et al.  Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  M. Lawson,et al.  Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. , 2004, The Journal of pediatrics.

[23]  L. Pantanowitz,et al.  Breast enlargement in 13 men who were seropositive for human immunodeficiency virus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  H. Ersöz,et al.  Causes of gynaecomastia in young adult males and factors associated with idiopathic gynaecomastia. , 2002, International journal of andrology.

[25]  D. D. Luis,et al.  Anabolizantes esteroideos y ginecomastia: Revisión de la literatura , 2001 .

[26]  D. D. de Luis,et al.  [Anabolic steroids and gynecomastia. Review of the literature]. , 2001, Anales de medicina interna.

[27]  C. Le Jeunne,et al.  [Drug-induced gynecomastia]. , 2000, Annales de medecine interne.

[28]  V. Barak,et al.  [Male breast cancer]. , 1989, Harefuah.

[29]  C. Niewoehner,et al.  Gynecomastia in a hospitalized male population. , 1984, The American journal of medicine.

[30]  F. Nuttall,et al.  Gynecomastia as a physical finding in normal men. , 1979, The Journal of clinical endocrinology and metabolism.

[31]  M. Williams,et al.  Gynecomastia. Its incidence, recognition and host characterization in 447 autopsy cases. , 1963, The American journal of medicine.